S. SamuelWeigtMD

Clinical Trials

• Safety Study of Aztreonam Lysine for Inhalation (AZLI) in the Treatment of Early Bronchiolitis Obliterans Syndrome (BOS) Start of enrollment: 2013 Mar 01

  Completed

  Phase 4

• Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2013 Jan 31

  Terminated

  Phase 2

• Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry Start of enrollment: 2014 Jun 01

  Recruiting

• CLAD Phenotype Specific Risk Factors and Mechanisms Start of enrollment: 2015 Dec 22

  Completed

• Pulmonary Fibrosis Foundation Patient Registry Start of enrollment: 2016 Mar 29

  Completed

• Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Start of enrollment: 2017 Jan 17

  Completed

  Phase 3

• Scleroderma Lung Study III - Combining Pirfenidone With Mycophenolate Start of enrollment: 2017 Nov 28

  Completed

  Phase 2

• A Trial to Evaluate the Safety of Long Term Treatment With Nintedanib in Patients With Scleroderma Related Lung Fibrosis Start of enrollment: 2017 Nov 27

  Completed

  Phase 3

• Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-2) Start of enrollment: 2019 Mar 29

  Active, not recruiting

  Phase 3

  Roles: Contact

• Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1) Start of enrollment: 2019 Apr 02

  Active, not recruiting

  Phase 3

  Roles: Contact

• Join now to see all